BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21173650)

  • 21. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
    Apter D; Wheeler CM; Paavonen J; Castellsagué X; Garland SM; Skinner SR; Naud P; Salmerón J; Chow SN; Kitchener HC; Teixeira JC; Jaisamrarn U; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; Mindel A; de Sutter P; Hardt K; Zahaf T; Descamps D; Struyf F; Lehtinen M; Dubin G;
    Clin Vaccine Immunol; 2015 Apr; 22(4):361-73. PubMed ID: 25651922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.
    Fernandes JV; Meissner Rde V; Carvalho MG; Fernandes TA; Azevedo PR; de Azevedo JW; de Araújo JM
    Mol Med Rep; 2011; 4(6):1321-6. PubMed ID: 21887467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
    Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
    APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type-specific prevalence of human papillomavirus by cervical cytology among women in Brasov, Romania.
    Moga MA; Irimie M; Oanta A; Pascu A; Burtea V
    Asian Pac J Cancer Prev; 2014; 15(16):6887-92. PubMed ID: 25169541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
    Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
    Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
    Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
    J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
    Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
    BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas.
    Torres KL; Mariño JM; Pires Rocha DA; de Mello MB; de Melo Farah HH; Reis RDS; Alves VDCR; Gomes E; Martins TR; Soares AC; de Oliveira CM; Levi JE
    PLoS One; 2018; 13(7):e0201262. PubMed ID: 30036381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.
    Ho GY; Burk RD; Klein S; Kadish AS; Chang CJ; Palan P; Basu J; Tachezy R; Lewis R; Romney S
    J Natl Cancer Inst; 1995 Sep; 87(18):1365-71. PubMed ID: 7658497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
    Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
    Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
    J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
    Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
    Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia.
    Fife KH; Cramer HM; Schroeder JM; Brown DR
    J Med Virol; 2001 Aug; 64(4):550-9. PubMed ID: 11468743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
    Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
    J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India.
    Kulkarni SS; Kulkarni SS; Vastrad PP; Kulkarni BB; Markande AR; Kadakol GS; Hiremath SV; Kaliwal S; Patil BR; Gai PB
    Asian Pac J Cancer Prev; 2011; 12(3):645-8. PubMed ID: 21627358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of current hormonal contraceptive use with type-specific HPV detection.
    Ghanem KG; Datta SD; Unger ER; Hagensee M; Shlay JC; Kerndt P; Hsu K; Koutsky LA
    Sex Transm Infect; 2011 Aug; 87(5):385-8. PubMed ID: 21772042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing a measure of health-related quality of life for women with cervical dysplasia resulting from human papillomavirus infection.
    Rao D; Gela N; Daley EM; Kattezham R; Rodriguez G; Cella D
    Int J STD AIDS; 2010 Oct; 21(10):697-701. PubMed ID: 21139148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simplified Convolutional Neural Network Application for Cervix Type Classification via Colposcopic Images.
    Pavlov V; Fyodorov S; Zavjalov S; Pervunina T; Govorov I; Komlichenko E; Deynega V; Artemenko V
    Bioengineering (Basel); 2022 May; 9(6):. PubMed ID: 35735482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.